ALISHA JAIN: Open Payments
NPI 1942718978 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,654 in 114 payments from 14 companies in 2025. Trend: 2023 $754 · 2024 $751 · 2025 $1,654
Food & beverage: $1,654
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 41 | $399 |
| Alkermes, Inc. | 14 | $307 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $189 |
| Neurocrine BioSciences, Inc. | 12 | $173 |
| Teva Pharmaceuticals USA, Inc. | 9 | $151 |
| Otsuka America Pharmaceutical, Inc. | 5 | $110 |
| Janssen Pharmaceuticals, Inc | 5 | $93 |
| ABBVIE INC. | 3 | $56 |
| Vanda Pharmaceuticals Inc. | 3 | $53 |
| Lundbeck LLC | 3 | $47 |
Products named: COBENFY, ARISTADA, CAPLYTA, INGREZZA, UZEDY, ABILIFY ASIMTUFII, SPRAVATO, VRAYLAR.
Industry payments across MO — which companies pay providers there.
